These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21228568)

  • 61. The Optimizing Patient Transfers, Impacting Medical Quality, andImproving Symptoms:Transforming Institutional Care approach: preliminary data from the implementation of a Centers for Medicare and Medicaid Services nursing facility demonstration project.
    Unroe KT; Nazir A; Holtz LR; Maurer H; Miller E; Hickman SE; La Mantia MA; Bennett M; Arling G; Sachs GA
    J Am Geriatr Soc; 2015 Jan; 63(1):165-9. PubMed ID: 25537789
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dual costs. Feds, states focus on ways to improve care and rein in spending for high-cost patients eligible for both Medicaid and Medicare.
    Daly R
    Mod Healthc; 2012 May; 42(19):28-30. PubMed ID: 22670270
    [No Abstract]   [Full Text] [Related]  

  • 63. The evolving role of the medical director of a dialysis facility.
    Maddux FW; Nissenson AR
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):326-30. PubMed ID: 25278550
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Public health surveillance in the dialysis setting: opportunities and challenges for using electronic health records.
    Wise ME; Lovell C
    Semin Dial; 2013; 26(4):399-406. PubMed ID: 23721477
    [TBL] [Abstract][Full Text] [Related]  

  • 65. How the ESRD quality incentive program could potentially improve quality of life for patients on dialysis.
    Moss AH; Davison SN
    Clin J Am Soc Nephrol; 2015 May; 10(5):888-93. PubMed ID: 25739850
    [TBL] [Abstract][Full Text] [Related]  

  • 66. ESRD Networks: past, present, and challenges for the future.
    Wish JB; Meyer KB
    Clin J Am Soc Nephrol; 2012 Nov; 7(11):1907-14. PubMed ID: 22977212
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The use of Health Care Financing Administration data for the development of a quality improvement project on the treatment of anemia.
    Eggers PW; Greer J; Jencks S
    Am J Kidney Dis; 1994 Aug; 24(2):247-54. PubMed ID: 8048432
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluating the Evidence behind Policy Mandates in US Dialysis Care.
    Erickson KF; Winkelmayer WC
    J Am Soc Nephrol; 2018 Dec; 29(12):2777-2779. PubMed ID: 30389727
    [No Abstract]   [Full Text] [Related]  

  • 69. Finding consistency in Medicare's quality ratings for dialysis providers.
    Stephens JM
    Nephrol News Issues; 2015 May; 29(5):16, 19-23. PubMed ID: 26197694
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of external oversight in quality activities: accreditation, credentialing, licensure, and deemed status.
    Wish JB
    Am J Kidney Dis; 1998 Dec; 32(6 Suppl 4):S177-81. PubMed ID: 9892388
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Treatment center characteristics associated with better outcomes: a role for the medical director?
    Spiegel BM
    Semin Dial; 2012 May; 25(3):296-8. PubMed ID: 22607212
    [No Abstract]   [Full Text] [Related]  

  • 72. Can better understanding and use of treatment center performance feedback improve hemodialysis care? A role for the medical director.
    DeOreo PB; Wilson R; Wish JB
    Semin Dial; 2012 May; 25(3):290-3. PubMed ID: 22494265
    [No Abstract]   [Full Text] [Related]  

  • 73. Outpatient Dialysis for Acute Kidney Injury: Progress and Pitfalls.
    Heung M
    Am J Kidney Dis; 2019 Oct; 74(4):523-528. PubMed ID: 31204193
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Challenges for dialysis facility medical directors and impact on patient care.
    Kossmann RJ
    Nephrol News Issues; 2013 Oct; 27(11):32, 34. PubMed ID: 24279209
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Assuring the Quality of Care: Understanding Common Deficiencies in Outpatient Dialysis Facilities.
    Payton J
    Nephrol Nurs J; 2022; 49(2):153-156. PubMed ID: 35503691
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evolution of quality and surgical risk assessment in the USA.
    Depalma RG
    Vascular; 2011 Apr; 19(2):68-76. PubMed ID: 21489931
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Should medical directors assume responsibility for facility-specific outcomes?
    Nissenson AR
    Semin Dial; 2012 May; 25(3):284-5. PubMed ID: 22494243
    [No Abstract]   [Full Text] [Related]  

  • 78. CMS-required visits adversely impact Seattle area hemodialysis program.
    Muczynski KA; Anderson SK
    Nephrol News Issues; 2014 Aug; 28(9):32-4. PubMed ID: 25223075
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dialysis medical directors' role in maintaining quality of care and responsibility for facility-specific patient outcomes: evolution and current status.
    Goldman RS; Latos DL
    Semin Dial; 2012 May; 25(3):286-90. PubMed ID: 22607211
    [No Abstract]   [Full Text] [Related]  

  • 80. Need to Reclassify Etiologies of ESRD on the CMS 2728 Medical Evidence Report.
    Tucker BM; Freedman BI
    Clin J Am Soc Nephrol; 2018 Mar; 13(3):477-479. PubMed ID: 29042463
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.